Table 2.
Analyte (parameter) | All participants N = 903 |
Male N = 358 |
Female N = 545 |
---|---|---|---|
Hemoglobin (g/dL)a | 13.6 (10.9–15.8) | 14.2 (10.6–16.4) | 13.3 (11.0–15.0) |
Haematocrit (%)a | 40.6 (32.5–47.3) | 42.2 (32.4–49.1) | 39.8 (32.7–45.4) |
Erythrocytes (10/L)a | 4.63 (3.60–5.60) | 4.7 (3.6–5.7) | 4.6 (3.7–5.4) |
Platelets (109/L)a | 220 (77–353) | 207 (60–336) | 229 (98–359) |
WBC (×1000) | 4.8 (3.0–7.7) | 4.9 (3.2–7.8) | 4.8 (3.0–7.2) |
MCH (pg) | 29.4 (25.0–33.4) | 30.0 (24.7–34.2) | 29.1 (25.0–32.6) |
MCV (fL) | 87 (75–99) | 89 (73–102) | 87 (76–97) |
MCHC (g/L) | 33.4 (32.0–35.2) | 33.5 (32.0–35.2) | 33.4 (32.1–35.2) |
Neutrophils (no 109/L) | 2.05 (1.05–3.78) | 2.04 (1.05–4.40) | 2.05 (1.05–3.60) |
Neutrophils (%)a | 43.0 (27.2–60.3) | 42.5 (26.0–62.4) | 43.5 (28.1–58.5) |
Lymphocytes (no 109/L) | 2.09 (1.15–3.51) | 2.05 (1.20–3.70) | 2.1 (1.1–3.4) |
Lymphocytes (%) | 43.9 (28.6–59.8) | 43.6 (27.9–60.8) | 44.2 (29.4–59.3) |
Monocytes (no 109/L) | 0.31 (0.17–0.57) | 0.33 (0.18–0.59) | 0.30 (0.17–0.55) |
Monocytes (%) | 6.5 (4.1–10.7) | 6.9 (4.3–12.1) | 6.3 (3.9–10.2) |
Eosinophils (no 109/L) | 0.15 (0.50–0.81) | 0.16 (0.04–0.82) | 0.14 (0.05–0.75) |
Eosinophils (%) | 3.2 (1–15.3) | 3.4 (1.0–15.9) | 3.0 (1.1–14.5) |
Basophils (no 109/L | 0.04 (0.02–0.08) | 0.04 (0.02–0.08) | 0.04 (0.02–0.08) |
Basophils (%) | 1.0 | 1.0 | 1.0 |
Sample of haematology reference ranges excluding those with hookworm infection, malaria infection, HIV infection and those uncertain of their age
aAnalytes significantly different by sex